Connor, Clark & Lunn Investment Management Ltd. Horizon Therapeutics Public LTD CO Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $81,163 - $94,906	820 Added 3.62%	23,498 $2.72 Million
Q2 2023 Aug 10, 2023	SELL	$96.34 - $112.38 $5,491 - $6,405	-57 Reduced 0.25%	22,678 $2.33 Million
Q1 2023 May 09, 2023	SELL	$107.32 - $113.5 $21,034 - $22,246	-196 Reduced 0.85%	22,735 $2.48 Million
Q4 2022 Feb 10, 2023	BUY	$62.39 - $113.8 $1.43 Million - $2.61 Million	22,931 New	22,931 $2.61 Million
Q2 2022 Aug 05, 2022	SELL	$79.4 - $116.36 $9.04 Million - $13.3 Million	-113,872 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $8.05 Million - $10.2 Million	93,159 Added 449.76%	113,872 $12 Million
Q4 2021 Feb 10, 2022	BUY	$98.56 - $119.91 $1.37 Million - $1.66 Million	13,880 Added 203.13%	20,713 $2.23 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $628,021 - $754,158	6,833 New	6,833 $748,000
Q2 2021 Aug 12, 2021	SELL	$86.24 - $95.92 $1.93 Million - $2.15 Million	-22,409 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $1.61 Million - $2.14 Million	22,409 New	22,409 $2.06 Million
Q3 2019 Nov 13, 2019	SELL	$23.0 - $27.97 $316,825 - $385,286	-13,775 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$22.81 - $28.48 $314,207 - $392,312	13,775 New	13,775 $331,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account